Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1144 of 5804
-
New depression pill icalcaprant enters Mid-Stage trial
Symptom relief Recruiting nowMajor depressive disorder (MDD; depression) is a mood disorder that causes a continued feeling of sadness and loss of interest. It is a common and serious illness that can cause both emotional and physical symptoms such as feelings of sadness, irritability, not being able to focu…
Phase: PHASE2 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Rural teens get depression help through mentor training study
Prevention Recruiting nowThis study will evaluate the usability, feasibility, and acceptability of a novel multi-level Just-In-Time Training (JITT) implementation strategy (JITT-EBP) that aims to equip mentors and mentor supervisors to implement evidence-based practices (EBPs) with fidelity using methods…
Phase: NA • Sponsor: University of Minnesota • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
Home workouts after stroke: a new hope for recovery?
Disease control OngoingThis study is a randomized controlled, open-label, blinded endpoint trial. The investigators aim to assess the efficacy and safety of home-based structured physical exercise in participants with acute ischemic stroke.
Phase: NA • Sponsor: Capital Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Old malaria and HIV drugs repurposed to fight ovarian cancer
Disease control Recruiting nowThis is a single-institution, single-arm study with a safety lead-in to determine if previously established safe doses of autophagy drugs, hydroxychloroquine (HCQ) and nelfinavir mesylate (NFV) will benefit ovarian cancer patients in a maintenance setting. Patients will receive t…
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New scan could reveal hidden diseases
Diagnosis Recruiting nowThe purpose of this study is to conduct clinical research on \[68Ga\] Ga-NI-FAPI-04 PET/CT imaging and further investigate its diagnostic value in fibroblast activation related diseases.
Phase: PHASE1, PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Simple ultrasound test may spot stroke risk before irregular heartbeat appears
Knowledge-focused Recruiting nowCryptogenic stroke is a type of stroke in which the cause of the blood clot cannot be identified, leaving many patients without a clear treatment plan and at high risk for another stroke. Current medical guidelines recommend blood-thinning medication (anticoagulation) only when a…
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
New hope for Hard-to-Treat neuroendocrine tumors?
Disease control Recruiting nowThis study will assess how well cabozantinib works and how safe it is in adults with a type of cancer called neuroendocrine tumors (NETs). These tumors can appear in all parts of the body. All participants in this study have already received at least one treatment that affects t…
Sponsor: Ipsen • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a diabetes drug shield your brain from stroke?
Disease control Recruiting nowOne important mechanism of action of GLP1 RA is the improvement in endothelial function, which may be evaluated by the assessment of cerebral vasodilatory reserve (CVR) in patients with severe ICAD. The investigators believe that GLP1 RA would be beneficial for patients with seve…
Phase: PHASE2, PHASE3 • Sponsor: National University of Singapore • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New heart implant aims to cut stroke risk without blood thinners
Disease control Recruiting nowThe WATCHMAN FLX Pro European registry is intended to gather real world clinical data for patients undergoing left atrial appendage closure (LAAC) with the WATCHMAN FLX™ Pro device. In a subregistry with approximately 300 patients, it is intended to use the VersaCross Connect™ LA…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Can you get the pneumonia shot while sick? new study finds out
⭐️ VACCINE ⭐️ Recruiting nowStreptococcus pneumoniae is responsible for serious infections associated to numerous hospitalizations and high rate of mortality. The incidence and therefore the burden of pneumococcal infections have been significantly reduced thanks to the use of pneumococcal conjugate vaccine…
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:02 UTC
-
Liver shunt may boost outcomes in liver cancer patients on immunotherapy
Disease control Recruiting nowThe NISTIPS TRITICC-4 study is a prospective, multicentre, non-interventional cohort study to analyze the effectiveness of transjugular intrahepatic portosystemic shunting (TIPS) in patients with Hepatocellular carcinoma (HCC) receiving atezolizumab plus bevacizumab as first-line…
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New combo aims to stop leukemia from coming back
Disease control Recruiting nowThis phase II trial studies how well giving olutasidenib with azacitidine, followed by olutasidenib maintenance, works in treating patients with IDH1-mutated acute myeloid leukemia (AML) who have received prior treatment with venetoclax plus a hypomethylating agent (HMA-Ven). Olu…
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Exercise after a blood clot in the lungs: a new hope for recovery?
Symptom relief Recruiting nowUp to half of patients with pulmonary embolism (PE) suffer from impaired quality of life, reduced physical capacity, and symptoms like shortness of breath even three months after diagnosis, despite standard treatment with anticoagulation (blood thinners). The randomized RehabPE t…
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
New study tests best way to prevent second stroke in seniors with a hole in the heart
Disease control Recruiting nowPatent foramen ovale (PFO) is an important mechanism of embolic stroke of undetermined source (ESUS). Current guidelines recommend PFO closure for high-risk PFO in patients younger than 60 years, and a recent retrospective cohort study from Taichung Veterans General Hospital has …
Sponsor: Taichung Veterans General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New device could spot dangerous brain pressure without needles
Diagnosis Not yet recruitingThe goal of this observational study is to evaluate the diagnostic accuracy of non-invasive intracranial pressure (ICP) and intracranial compliance (ICC) pulse morphology and associated parameters (such as the P2/P1 ratio and nTTP) obtained with the brain4care system for the scre…
Sponsor: Braincare USA Corp • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC
-
New hope for Hard-to-Treat cancers? early trial of HMPL-A251 begins
Disease control Recruiting nowThis is a first-in-human (FIH), phase Ⅰ/Ⅱa, open-label, multicenter clinical study of HMPL-A251 monotherapy in adult participants with unresectable, advanced or metastatic HER2-expressing solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Hutchmed • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Experimental drug aims to shield dialysis Patients' brains
Disease control Recruiting nowCognitive decline is increasingly recognized among patients receiving maintenance hemodialysis (HD). This can include trouble remembering, slower thinking or mentally feeling foggy. This research is being done to determine if a new medication (AV-001) can protect the brain from …
Phase: PHASE2 • Sponsor: London Health Sciences Centre Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
AI reads CT scans to tell old from new spine breaks
Diagnosis Not yet recruitingOsteoporotic vertebral compression fractures are common in older adults and may present as either acute or chronic fractures. Correctly distinguishing acute from chronic fractures is clinically important because treatment strategies and management decisions differ depending on fr…
Sponsor: Xin Fan • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
New hope for pancreatic cancer: experimental drug combo enters human trials
Disease control Recruiting nowThis study is designed to evaluate the safety and efficacy of KN510713 in combination with mFOLFIRINOX in patients with locally advanced or metastatic pancreatic cancer. The study will be conducted in two parts: Part 1 (Dose-finding) and Part 2 (Dose expansion).
Phase: PHASE1, PHASE2 • Sponsor: New Cancer Cure-Bio Co.,Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Could probiotics be the key to lowering uric acid?
Disease control Recruiting nowThe overall aim of the project is to determine whether a daily intake of health-promoting bacteria, known as probiotics, with or without a dietary fiber, affects uric acid levels in individuals with elevated levels of uric acid in the blood (hyperuricemia). Additionally, the proj…
Phase: NA • Sponsor: Örebro University, Sweden • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC